Top

BMC Cancer

Published in:

Open Access 01-12-2023 | Obesity | Research

Alterations in the mammary gland and tumor microenvironment of formerly obese mice

Authors: Genevra Kuziel, Brittney N. Moore, Grace P. Haugstad, Yue Xiong, Abbey E. Williams, Lisa M. Arendt

Published in: BMC Cancer | Issue 1/2023

Abstract

Background

Obesity is a risk factor for breast cancer, and women with obesity that develop breast cancer have a worsened prognosis. Within the mammary gland, obesity causes chronic, macrophage-driven inflammation and adipose tissue fibrosis. Weight loss is a recommended intervention to resolve obesity, but the impact of weight loss on the mammary gland microenvironment and in tumors has not been well identified.

Methods

To examine the effects of weight loss following obesity, mice were fed a high-fat diet for 16 weeks to induce obesity, then switched to a low-fat diet for 6 weeks. We examined changes in immune cells, including fibrocytes, which are myeloid lineage cells that have attributes of both macrophages and myofibroblasts, and collagen deposition within the mammary glands of non-tumor-bearing mice and within the tumors of mice that were transplanted with estrogen receptor alpha positive TC2 tumor cells.

Results

In formerly obese mice, we observed reduced numbers of crown-like structures and fibrocytes in mammary glands, while collagen deposition was not resolved with weight loss. Following transplant of TC2 tumor cells into the mammary glands of lean, obese, and formerly obese mice, diminished collagen deposition and cancer-associated fibroblasts were observed in tumors from formerly obese mice compared to obese mice. Within tumors of obese mice, increased myeloid-derived suppressor cells and diminished CD8⁺ T cells were identified, while the microenvironment of tumors of formerly obese mice were more similar to tumors from lean mice. When TC2 tumor cells were mixed with CD11b⁺CD34⁺ myeloid progenitor cells, which are the cells of origin for fibrocytes, and transplanted into mammary glands of lean and obese mice, collagen deposition within the tumors of both lean and obese was significantly greater than when tumor cells were mixed with CD11b⁺CD34⁻ monocytes or total CD45⁺ immune cells.

Conclusions

Overall, these studies demonstrate that weight loss resolved some of the microenvironmental conditions within the mammary gland that may contribute to tumor progression. Additionally, fibrocytes may contribute to early collagen deposition in mammary tumors of obese mice leading to the growth of desmoplastic tumors.

Available only for authorised users

World Health Organization.(2021) Obesity and overweight. http://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Date accessed: 06/01/2023.

National Institute of Diabetes and Digestive and Kidney Diseases. (2021) Overweight & Obesity Statistics. https://www.niddk.nih.gov/health-information/health-statistics/overweight-obesity. Date accessed: 06/01/2023.

Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625–38.CrossRefPubMed

Petrelli JM, Calle EE, Rodriguez C, Thun MJ. Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women. Cancer Causes Control. 2002;13(4):325–32. https://doi.org/10.1023/a:1015288615472.CrossRefPubMed

Suzuki R, Orsini N, Saji S, Key TJ, Wolk A. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status–a meta-analysis. Int J Cancer J. 2009;124(3):698–712. https://doi.org/10.1002/ijc.23943.CrossRef

Ewertz M, Jensen MB, Gunnarsdottir KA, Hojris I, Jakobsen EH, Nielsen D, et al. Effect of obesity on prognosis after early-stage breast cancer. J Clin Oncol. 2011;29(1):25–31. https://doi.org/10.1200/JCO.2010.29.7614.CrossRefPubMed

Seo BR, Bhardwaj P, Choi S, Gonzalez J, Andresen Eguiluz RC, Wang K, et al. Obesity-dependent changes in interstitial ECM mechanics promote breast tumorigenesis. Sci Transl Med. 2015;7(301):301ra130. https://doi.org/10.1126/scitranslmed.3010467.CrossRefPubMedPubMedCentral

Christou NV, Lieberman M, Sampalis F, Sampalis JS. Bariatric surgery reduces cancer risk in morbidly obese patients. Surg Obes Relat Dis. 2008;4(6):691–5. https://doi.org/10.1016/j.soard.2008.08.025.CrossRefPubMed

Schauer DP, Feigelson HS, Koebnick C, Caan B, Weinmann S, et al. Bariatric surgery and the risk of cancer in a large multisite cohort. Ann Surg. 2019;269(1):95–101. https://doi.org/10.1097/SLA.0000000000002525.CrossRefPubMed

10.

Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res. 2005;46(11):2347–55. https://doi.org/10.1194/jlr.M500294-JLR200.CrossRefPubMed

11.

Aron-Wisnewsky J, Tordjman J, Poitou C, Darakhshan F, Hugol D, Basdevant A, et al. Human adipose tissue macrophages: M1 and M2 cell surface markers in subcutaneous and omental depots and after weight loss. J Clin Endocrinol Metab. 2009;94(11):4619–23. https://doi.org/10.1210/jc.2009-0925.CrossRefPubMed

12.

Kovacikova M, Sengenes C, Kovacova Z, Siklova-Vitkova M, Klimcakova E, Polak J, et al. Dietary intervention-induced weight loss decreases macrophage content in adipose tissue of obese women. Int J Obes. 2011;35(1):91–8. https://doi.org/10.1038/ijo.2010.112.CrossRef

13.

Ruggiero AD, Key CCC, Kavanagh K. Adipose tissue macrophage polarization in healthy and unhealthy obesity. Front Nutr. 2021;8:625331. https://doi.org/10.3389/fnut.2021.625331.CrossRefPubMedPubMedCentral

14.

Cancello R, Zulian A, Gentilini D, Mencarelli M, Della Barba A, Maffei M, et al. Permanence of molecular features of obesity in subcutaneous adipose tissue of ex-obese subjects. Int J Obesity. 2013;37(6):867–73. https://doi.org/10.1038/ijo.2013.7.CrossRef

15.

Liu Y, Aron-Wisnewsky J, Marcelin G, Genser L, Le Naour G, Torcivia A, et al. Accumulation and changes in composition of collagens in subcutaneous adipose tissue after bariatric surgery. J Clin Endocrinol Metabol. 2016;101(1):293–304. https://doi.org/10.1210/jc.2015-3348.CrossRef

16.

Springer NL, Iyengar NM, Bareja R, Verma A, Jochelson MS, Giri DD, et al. Obesity-associated extracellular matrix remodeling promotes a macrophage phenotype similar to tumor-associated macrophages. Am J Pathol. 2019;189(10):2019–35. https://doi.org/10.1016/j.ajpath.2019.06.005.CrossRefPubMedPubMedCentral

17.

Kuziel GM, Moore BN, Haugstad GP, Arendt LM. Fibrocytes enhance mammary gland fibrosis in obesity. FASEB J. 2023;37: e23049. https://doi.org/10.1096/fj202300399RR.CrossRefPubMed

18.

Reilkoff RA, Bucala R, Herzog EL. Fibrocytes: emerging effector cells in chronic inflammation. Nat Rev Immunol. 2011;11(6):427–35. https://doi.org/10.1038/nri2990.CrossRefPubMedPubMedCentral

19.

Keeley EC, Mehrad B, Strieter RM. Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis. Int J Biochem Cell Biol. 2010;42(4):535–42. https://doi.org/10.1016/j.biocel.2009.10.014.CrossRefPubMed

20.

Cao T, Rajasingh S, Rajasingh J. Circulating fibrocytes serve as a marker for clinical diagnosis. Ann Transl Med. 2016;4(Suppl 1):S38. https://doi.org/10.21037/atm.2016.10.26.CrossRefPubMedPubMedCentral

21.

Pilling D, Fan T, Huang D, Kaul B, Gomer RH. Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLos One. 2009;4(10): e7475. https://doi.org/10.1371/journal.pone.0007475.CrossRefPubMedPubMedCentral

22.

Weigert A, Zheng X, Nenzel A, Turkowski K, Günther S, Strack E, et al. Fibrocytes boost tumor-supportive phenotypic switches in the lung cancer niche via the endothelin system. Nat Commun. 2022;13(1):6078. https://doi.org/10.1038/s41467-022-33458-8.CrossRefPubMedPubMedCentral

23.

Mitsuhashi A, Koyama K, Ogino H, Afroj T, Nguyen NT, Yoneda H, et al. Identification of fibrocyte cluster in tumors reveals the role in antitumor immunity by PD-L1 blockade. Cell Rep. 2023;42(3): 112162. https://doi.org/10.1016/j.celrep.2023.112162.CrossRefPubMed

24.

Kuziel G, Thompson V, D’Amato JV, Arendt LM. Stromal CCL2 signaling promotes mammary tumor fibrosis through recruitment of myeloid-lineage cells. Cancers. 2020;12(8): e23049. https://doi.org/10.3390/cancers12082083.CrossRef

25.

Barth PJ, Ebrahimsade S, Ramaswamy A, Moll R. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions. Virchows Arch. 2002;440(3):298–303.CrossRefPubMed

26.

Yazhou C, Wenlv S, Weidong Z, Licun W. Clinicopathological significance of stromal myofibroblasts in invasive ductal carcinoma of the breast. Tumour Biol. 2004;25(5–6):290–5. https://doi.org/10.1159/000081394.CrossRefPubMed

27.

Hadjantonakis AK, Gertsenstein M, Ikawa M, Okabe M, Nagy A. Generating green fluorescent mice by germline transmission of green fluorescent ES cells. Mech Dev. 1998;76(1–2):79–90.CrossRefPubMed

28.

Chamberlin T, D’Amato JV, Arendt LM. Obesity reversibly depletes the basal cell population and enhances mammary epithelial cell estrogen receptor alpha expression and progenitor activity. Breast Cancer Res. 2017;19(1):128. https://doi.org/10.1186/s13058-017-0921-7.CrossRefPubMedPubMedCentral

29.

Barcus CE, O’Leary KA, Brockman JL, Rugowski DE, Liu Y, Garcia N, et al. Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells. Breast Cancer Res. 2017;19(1):9. https://doi.org/10.1186/s13058-017-0801-1.CrossRefPubMedPubMedCentral

30.

Alexander CM, Puchalski J, Klos KS, Badders N, Ailles L, Kim CF, et al. Separating stem cells by flow cytometry: reducing variability for solid tissues. Cell Stem Cell. 2009;5(6):579–83. https://doi.org/10.1016/j.stem.2009.11.008.CrossRefPubMedPubMedCentral

31.

Wegner KA, Keikhosravi A, Eliceiri KW, Vezina CM. Fluorescence of picrosirius red multiplexed with immunohistochemistry for the quantitative assessment of collagen in tissue sections. J Histochem Cytochem. 2017;65(8):479–90. https://doi.org/10.1369/0022155417718541.CrossRefPubMedPubMedCentral

32.

Chamberlin T, Clack M, Silvers C, Kuziel G, Thompson V, Johnson H, et al. Targeting obesity-induced macrophages during preneoplastic growth promotes mammary epithelial stem/progenitor activity, DNA damage, and tumor formation. Cancer Res. 2020;80(20):4465–75. https://doi.org/10.1158/0008-5472.Can-20-0789.CrossRefPubMedPubMedCentral

33.

Landini G, Martinelli G, Piccinini F. Colour deconvolution: stain unmixing in histological imaging. Bioinformatics. 2021;37(10):1485–7. https://doi.org/10.1093/bioinformatics/btaa847.CrossRefPubMed

34.

Kamikawa A, Ichii O, Yamaji D, Imao T, Suzuki C, Okamatsu-Ogura Y, et al. Diet-induced obesity disrupts ductal development in the mammary glands of nonpregnant mice. Dev Dyn. 2009;238(5):1092–9. https://doi.org/10.1002/dvdy.21947.CrossRefPubMed

35.

Wolfson B, Zhang Y, Gernapudi R, Duru N, Yao Y, Lo PK, et al. A high-fat diet promotes mammary gland myofibroblast differentiation through microRNA 140 downregulation. Mol Cell Biol. 2017;37(4):e00461-e516. https://doi.org/10.1128/MCB.00461-16.CrossRefPubMedPubMedCentral

36.

Hillers-Ziemer LE, McMahon RQ, Hietpas M, Paderta G, LeBeau J, McCready J, Arendt LM. Obesity promotes cooperation of cancer stem-like cells and macrophages to enhance mammary tumor angiogenesis. Cancers (Basel). 2020;12:502. https://doi.org/10.3390/cancers12020502.CrossRefPubMed

37.

Hillers-Ziemer LE, Williams AE, Janquart A, Grogan C, Thompson V, Sanchez A, et al. Obesity-activated lung stromal cells promote myeloid lineage cell accumulation and breast cancer metastasis. Cancers. 2021;13(5):1005. https://doi.org/10.3390/cancers13051005.CrossRefPubMedPubMedCentral

38.

Li K, Shi H, Zhang B, Ou X, Ma Q, Chen Y, et al. Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer. Signal Transduct Targ Ther. 2021;6(1):362. https://doi.org/10.1038/s41392-021-00670-9.CrossRef

39.

Groth C, Hu X, Weber R, Fleming V, Altevogt P, Utikal J, et al. Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression. Br J Cancer. 2019;120(1):16–25. https://doi.org/10.1038/s41416-018-0333-1.CrossRefPubMed

40.

Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med. 1994;1(1):71–81.CrossRefPubMedPubMedCentral

41.

Mitsuhashi A, Goto H, Saijo A, Trung VT, Aono Y, Ogino H, et al. Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab. Nat Commun. 2015;6:8792. https://doi.org/10.1038/ncomms9792.CrossRefPubMed

42.

Terai S, Fushida S, Tsukada T, Kinoshita J, Oyama K, Okamoto K, et al. Bone marrow derived “fibrocytes” contribute to tumor proliferation and fibrosis in gastric cancer. Gastric Cancer. 2015;18(2):306–13. https://doi.org/10.1007/s10120-014-0380-0.CrossRefPubMed

43.

de GarciaAlba C, Buendia-Roldan I, Salgado A, Becerril C, Ramirez R, Gonzalez Y, et al. Fibrocytes contribute to inflammation and fibrosis in chronic hypersensitivity pneumonitis through paracrine effects. Am J Respir Crit Care Med. 2015;191(4):427–36. https://doi.org/10.1164/rccm.201407-1334OC.CrossRef

44.

Wang JF, Jiao H, Stewart TL, Shankowsky HA, Scott PG, Tredget EE. Fibrocytes from burn patients regulate the activities of fibroblasts. Wound Repair Regen. 2007;15(1):113–21. https://doi.org/10.1111/j.1524-475X.2006.00192.x.CrossRefPubMed

45.

Toyama BH, Hetzer MW. Protein homeostasis: live long, won’t prosper. Nat Rev Mol Cell Biol. 2013;14(1):55–61. https://doi.org/10.1038/nrm3496.CrossRefPubMedPubMedCentral

46.

Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest. 2004;114(3):438–46.CrossRefPubMedPubMedCentral

47.

Smadja DM, Dorfmuller P, Guerin CL, Bieche I, Badoual C, Boscolo E, et al. Cooperation between human fibrocytes and endothelial colony-forming cells increases angiogenesis via the CXCR4 pathway. Thromb Haemost. 2014;112(5):1002–13. https://doi.org/10.1160/th13-08-0711.CrossRefPubMedPubMedCentral

48.

Moore BB, Murray L, Das A, Wilke CA, Herrygers AB, Toews GB. The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. Am J Respir Cell Mol Biol. 2006;35(2):175–81. https://doi.org/10.1165/rcmb.2005-0239OC.CrossRefPubMedPubMedCentral

49.

Aono Y, Kishi M, Yokota Y, Azuma M, Kinoshita K, Takezaki A, et al. Role of platelet-derived growth factor/platelet-derived growth factor receptor axis in the trafficking of circulating fibrocytes in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2014;51(6):793–801. https://doi.org/10.1165/rcmb.2013-0455OC.CrossRefPubMed

50.

Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest. 2006;116(1):115–24. https://doi.org/10.1172/JCI24335.CrossRefPubMed

51.

Christiansen T, Richelsen B, Bruun JM. Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes (Lond). 2005;29(1):146–50. https://doi.org/10.1038/sj.ijo.0802839.CrossRefPubMed

52.

Fibbe WE, Goselink HM, Van Eeden G, Van Damme J, Billiau A, Voogt PJ, et al. Proliferation of myeloid progenitor cells in human long-term bone marrow cultures is stimulated by interleukin-1 beta. Blood. 1988;72(4):1242–7.CrossRefPubMed

53.

Brugger W, Möcklin W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin. Blood. 1993;81(10):2579–84.CrossRefPubMed

54.

Tack CJ, Stienstra R, Joosten LA, Netea MG. Inflammation links excess fat to insulin resistance: the role of the interleukin-1 family. Immunol Rev. 2012;249(1):239–52. https://doi.org/10.1111/j.1600-065X.2012.01145.x.CrossRefPubMed

55.

Halle M, Berg A, Northoff H, Keul J. Importance of TNF-alpha and leptin in obesity and insulin resistance: a hypothesis on the impact of physical exercise. Exerc Immunol Rev. 1998;4:77–94.PubMed

56.

Han MS, White A, Perry RJ, Camporez JP, Hidalgo J, Shulman GI, et al. Regulation of adipose tissue inflammation by interleukin 6. Proc Natl Acad Sci U S A. 2020;117(6):2751–60. https://doi.org/10.1073/pnas.1920004117.CrossRefPubMedPubMedCentral

57.

Maliniak ML, Miller-Kleinhenz J, Cronin-Fenton DP, Lash TL, Gogineni K, Janssen EAM, et al. Crown-like structures in breast adipose tissue: early evidence and current issues in breast cancer. Cancers. 2021;13(9):2222. https://doi.org/10.3390/cancers13092222.CrossRefPubMedPubMedCentral

58.

Jaitin DA, Adlung L, Thaiss CA, Weiner A, Li B, Descamps H, et al. Lipid-associated macrophages control metabolic homeostasis in a Trem2-dependent manner. Cell. 2019;178(3):686-98.e14. https://doi.org/10.1016/j.cell.2019.05.054.CrossRefPubMedPubMedCentral

59.

Cottam MA, Caslin HL, Winn NC, Hasty AH. Multiomics reveals persistence of obesity-associated immune cell phenotypes in adipose tissue during weight loss and weight regain in mice. Nat Commun. 2022;13(1):2950. https://doi.org/10.1038/s41467-022-30646-4.CrossRefPubMedPubMedCentral

60.

Hildreth AD, Ma F, Wong YY, Sun R, Pellegrini M, O’Sullivan TE. Single-cell sequencing of human white adipose tissue identifies new cell states in health and obesity. Nat Immunol. 2021;22(5):639–53. https://doi.org/10.1038/s41590-021-00922-4.CrossRefPubMedPubMedCentral

61.

Hill DA, Lim H-W, Kim YH, Ho WY, Foong YH, Nelson VL, et al. Distinct macrophage populations direct inflammatory versus physiological changes in adipose tissue. PNAS. 2018;115(22):E5096–105. https://doi.org/10.1073/pnas.1802611115.CrossRefPubMedPubMedCentral

62.

Kratz M, Coats BR, Hisert KB, Hagman D, Mutskov V, Peris E, et al. Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages. Cell Metab. 2014;20(4):614–25. https://doi.org/10.1016/j.cmet.2014.08.010.CrossRefPubMedPubMedCentral

63.

Xu X, Grijalva A, Skowronski A, van Eijk M, Serlie MJ, Ferrante AW Jr. Obesity activates a program of lysosomal-dependent lipid metabolism in adipose tissue macrophages independently of classic activation. Cell Metab. 2013;18(6):816–30. https://doi.org/10.1016/j.cmet.2013.11.001.CrossRefPubMedPubMedCentral

64.

Weinstock A, Brown EJ, Garabedian ML, Pena S, Sharma M, Lafaille J, et al. Single-cell RNA sequencing of visceral adipose tissue leukocytes reveals that caloric restriction following obesity promotes the accumulation of a distinct macrophage population with features of phagocytic cells. Immunometab. 2019;1:1900008. https://doi.org/10.20900/immunometab20190008.CrossRef

65.

Zhu Y, Aupperlee MD, Zhao Y, Siow Tan Y, Kirk EL, Sun X, et al. Pubertal and adult windows of susceptibility to a high animal fat diet in Trp53-null mammary tumorigenesis. Oncotarget. 2016;7:83409. https://doi.org/10.18632/oncotarget.13112.CrossRefPubMedPubMedCentral

66.

Atashgaran V, Wrin J, Barry SC, Dasari P, Ingman WV. Dissecting the biology of menstrual cycle-associated breast cancer risk. Front Oncology. 2016;6:267. https://doi.org/10.3389/fonc.2016.00267.CrossRef

67.

Yu YR, O’Koren EG, Hotten DF, Kan MJ, Kopin D, Nelson ER, et al. A protocol for the comprehensive flow cytometric analysis of immune cells in normal and inflamed murine non-lymphoid tissues. PLos One. 2016;11(3): e0150606. https://doi.org/10.1371/journal.pone.0150606.CrossRefPubMedPubMedCentral

68.

Ibrahim AM, Moss MA, Gray Z, Rojo MD, Burke CM, Schwertfeger KL, et al. Diverse macrophage populations contribute to the inflammatory microenvironment in premalignant lesions during localized invasion. Front Oncol. 2020;10: 569985. https://doi.org/10.3389/fonc.2020.569985.CrossRefPubMedPubMedCentral

69.

Casbon A-J, Reynaud D, Park C, Khuc E, Gan DD, Schepers K, et al. Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils. PNAS. 2015;112(6):E566–75. https://doi.org/10.1073/pnas.1424927112.CrossRefPubMedPubMedCentral

70.

Robinson A, Burgess M, Webb S, Louwe PA, Ouyang Z, Skola D, et al. Systemic influences of mammary cancer on monocytes in mice. Cancers. 2022;14(3):833. https://doi.org/10.3390/cancers14030833.CrossRefPubMedPubMedCentral

71.

Marvel D, Gabrilovich DI. Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected. J Clin Invest. 2015;125(9):3356–64. https://doi.org/10.1172/jci80005.CrossRefPubMedPubMedCentral

72.

Morales JK, Kmieciak M, Knutson KL, Bear HD, Manjili MH. GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells. Breast Cancer Res Treat. 2010;123(1):39–49. https://doi.org/10.1007/s10549-009-0622-8.CrossRefPubMed

73.

Dolcetti L, Peranzoni E, Ugel S, Marigo I, Fernandez Gomez A, Mesa C, et al. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur J Immunol. 2010;40(1):22–35. https://doi.org/10.1002/eji.200939903.CrossRefPubMed

74.

Reich B, Schmidbauer K, Rodriguez Gomez M, Johannes Hermann F, Göbel N, Brühl H, et al. Fibrocytes develop outside the kidney but contribute to renal fibrosis in a mouse model. Kidney Int. 2013;84(1):78–89. https://doi.org/10.1038/ki.2013.84.CrossRefPubMed

75.

Hong KM, Belperio JA, Keane MP, Burdick MD, Strieter RM. Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma. J Biol Chem. 2007;282(31):22910–20. https://doi.org/10.1074/jbc.M703597200.CrossRefPubMed

76.

Abe R, Donnelly SC, Peng T, Bucala R, Metz CN. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol. 2001;166(12):7556–62. https://doi.org/10.4049/jimmunol.166.12.7556.CrossRefPubMed

77.

Bowers LW, Doerstling SS, Shamsunder MG, Lineberger CG, Rossi EL, Montgomery SA, et al. Reversing the genomic, epigenetic, and triple-negative breast cancer-enhancing effects of obesity. Cancer Prev Res. 2022;15(9):581–94. https://doi.org/10.1158/1940-6207.Capr-22-0113.CrossRef

78.

Sipe LM, Chaib M, Korba EB, Jo H, Lovely MC, Counts BR, et al. Response to immune checkpoint blockade improved in pre-clinical model of breast cancer after bariatric surgery. Elife. 2022;11:e79143. https://doi.org/10.7554/eLife.79143.CrossRefPubMedPubMedCentral

79.

Rossi EL, de Angel RE, Bowers LW, Khatib SA, Smith LA, Van Buren E, et al. Obesity-associated alterations in inflammation, epigenetics, and mammary tumor growth persist in formerly obese mice. Cancer Prev Res. 2016;9(5):339–48. https://doi.org/10.1158/1940-6207.capr-15-0348.CrossRef

80.

Catteau X, Simon P, Jondet M, Vanhaeverbeek M, Noel J-C. Quantification of stromal reaction in breast carcinoma and its correlation with tumor grade and free progression survival. PLos One. 2019;14(3): e0210263. https://doi.org/10.1371/journal.pone.0210263.CrossRefPubMedPubMedCentral

81.

Kramer CJH, Vangangelt KMH, van Pelt GW, Dekker TJA, Tollenaar RAEM, Mesker WE. The prognostic value of tumour - stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review. Breast Cancer Res Treat. 2019;173(1):55–64. https://doi.org/10.1007/s10549-018-4987-4.CrossRefPubMed

Title: Alterations in the mammary gland and tumor microenvironment of formerly obese mice
Authors: Genevra Kuziel
Brittney N. Moore
Grace P. Haugstad
Yue Xiong
Abbey E. Williams
Lisa M. Arendt
Publication date: 01-12-2023
Publisher: BioMed Central
Keywords: Obesity
Obesity
Breast Cancer
Breast Cancer
Published in: BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI: https://doi.org/10.1186/s12885-023-11688-3

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2023

Failure to follow up abnormal test results associated with cervical cancer in primary and ambulatory care: a systematic review

Analysis of the expression and prognostic significance of DDK complex in Hepatocarcinoma

CD1C is associated with breast cancer prognosis and immune infiltrates

Effects of sleep disturbances and circadian rhythms modifications on cognition in breast cancer women before and after adjuvant chemotherapy: the ICANSLEEP-1 protocol

Skeletal muscle index is associated with long term outcomes after lobectomy for non-small cell lung cancer

Association between IL-10 gene polymorphisms (− 1082 A/G, -819 T/C, -592 A/C) and hepatocellular carcinoma: a meta-analysis and trial sequential analysis

Keynote webinar | Spotlight on antibody–drug conjugates in cancer